A two-year-old lawsuit that argues against rules governing the entrance of generics into the Canadian marketplace goes to a federal court today, with generics makers arguing for a shorter exclusivity period on branded meds. Report
A two-year-old lawsuit that argues against rules governing the entrance of generics into the Canadian marketplace goes to a federal court today, with generics makers arguing for a shorter exclusivity period on branded meds. Report